NAM
MRNA icon

Nexpoint Asset Management’s Moderna MRNA Stock Holding History

Nexpoint Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,000
Closed -$283K – 161
2020
Q3 		$283K Hold
4,000
– – 0.06% 133
2020
Q2 		$257K Sell
4,000
-4,000
-50% -$219K 0.06% 156
2020
Q1 		$240K Buy
+8,000
New +$184K 0.05% 179

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nexpoint Asset Management's MRNA Position: Q4 2020 in Review

Nexpoint Asset Management sold out of Moderna (MRNA) in Q4 2020, closing a stake of 4,000 shares — an estimated $283K sold.

Nexpoint Asset Management first reported a position in MRNA in Q1 2020 and held it in 3 quarters. The position peaked at $283K in Q3 2020. 717 funds tracked by Wall St. Rank hold MRNA as of Q4 2020.

  • Nexpoint Asset Management reported no remaining Moderna position as of Q4 2020 after selling out during the quarter.
  • Nexpoint Asset Management sold 4,000 Moderna shares in Q4 2020, an estimated $283K.
  • Nexpoint Asset Management first reported a position in Moderna in Q1 2020 and held it in 3 quarters.
  • Nexpoint Asset Management's Moderna position peaked at $283K in Q3 2020.
  • 717 funds tracked by Wall St. Rank held Moderna as of Q4 2020.

Based on Nexpoint Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.